Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder
Authors:
- Claudia PisanuCPClaudia Pisanu
- Eleni Merkouri PapadimaEPEleni Merkouri Papadima
- Carla MelisCMCarla Melis
- Donatella CongiuDCDonatella Congiu
- Annalisa LoizeddaALAnnalisa Loizedda
- Nicola OrrùNONicola Orrù
- Stefano CalzaStefano Calza
- Sandro OrrùSandro Orrù
- Carlo CarcassiCCCarlo Carcassi
- Giovanni SeverinoGSGiovanni Severino
- Raffaella ArdauRARaffaella Ardau
- Caterina ChillottiCCCaterina Chillotti
Open Access
- 30 November 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (23) , 6040
Abstract
Lithium is the mainstay in the maintenance of bipolar disorder (BD) and the most efficacious pharmacological treatment in suicide prevention. Nevertheless, its use is hampered by a high interindividual variability and important side effects. Genetic and epigenetic factors have been suggested to modulate lithium response, but findings so far have not allowed identifying molecular targets with predictive value. In this study we used next generation sequencing to measure genome-wide miRNA expression in lymphoblastoid cell lines from BD patients excellent responders (ER, n = 12) and non-responders (NR, n = 12) to lithium. These data were integrated with microarray genome-wide expression data to identify pairs of miRNA/mRNA inversely and significantly correlated. Significant pairs were prioritized based on strength of association and in-silico miRNA target prediction analyses to select candidates for validation with qRT-PCR. Thirty-one miRNAs were differentially expressed in ER vs. NR and inversely correlated with 418 genes differentially expressed between the two groups. A total of 331 of these correlations were also predicted by in-silico algorithms. miR-320a and miR-155-3p, as well as three of their targeted genes (CAPNS1 (Calpain Small Subunit 1) and RGS16 (Regulator of G Protein Signaling 16) for miR-320, SP4 (Sp4 Transcription Factor) for miR-155-3p) were validated. These miRNAs and mRNAs were previously implicated in psychiatric disorders (miR-320a and SP4), key processes of the central nervous system (CAPNS1, RGS16, SP4) or pathways involved in mental illnesses (miR-155-3p). Using an integrated approach, we identified miRNAs and their targeted genes potentially involved in lithium response in BD.Keywords
Funding Information
- Fondazione Umberto Veronesi (Fellowship)
This publication has 59 references indexed in Scilit:
- Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patientsPharmacological Research, 2013
- Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) ReportPLOS ONE, 2013
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genomeGenome Biology, 2009
- MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatmentInternational Journal of Neuropsychopharmacology, 2009
- Association study in a Sardinian sample between bipolar disorder and the nuclear receptor REV‐ERBα gene, a critical component of the circadian clock systemBipolar Disorders, 2009
- MicroRNA-155 modulates the interleukin-1 signaling pathway in activated human monocyte-derived dendritic cellsProceedings of the National Academy of Sciences, 2009
- Prophylactic treatment response in bipolar disorder: Results of a naturalistic observation studyJournal of Affective Disorders, 2007
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003